Skip to main content
Livermore
Livermore
ZHEN

Barclays PLC

SEC CIK
0000312069
Latest filing
Aug 14, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by Barclays PLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
13,933
Value
$545.1K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RIGL by Barclays PLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202613,933$545.1K<0.1%−1,265−8.3%ReducedHolders
Q1 202615,198$411.0K<0.1%−60,161−79.8%ReducedHolders
Q4 202575,359$3.23M<0.1%+24,294+47.6%AddedHolders
Q3 202551,065$1.45M<0.1%−8,741−14.6%ReducedHolders
Q2 202559,806$1.12M<0.1%+30,595+104.7%AddedHolders
Q1 202529,211$525.5K<0.1%−2,125−6.8%ReducedHolders
Q4 202431,336$527.1K<0.1%+3,991+14.6%AddedHolders
Q3 202427,345$442.4K<0.1%+16,772+158.6%AddedHolders
Q2 202410,573$86.9K<0.1%−4,484−29.8%ReducedConverted for a 1-for-10 splitHolders
Q1 2024150,568$222.8K<0.1%−95,935−38.9%ReducedHolders
Q4 2023246,503$357.4K<0.1%+204,855+491.9%AddedHolders
Q3 202341,648$45.0K<0.1%−3,848−8.5%ReducedHolders
Q2 202345,496$58.7K<0.1%−53,212−53.9%ReducedHolders
Q1 202398,708$130.3K<0.1%+52,372+113.0%AddedHolders
Q4 202246,336$69.5K<0.1%+39,019+533.3%AddedHolders
Q3 20227,317$9.00K<0.1%−1,344−15.5%ReducedHolders
Q2 20228,661$10.0K<0.1%−39,867−82.2%ReducedHolders
Q1 202248,528$145.0K<0.1%−158,857−76.6%ReducedHolders
Q4 2021207,385$550.0K<0.1%−149,859−41.9%ReducedHolders
Q3 2021357,244$1.30M<0.1%+120,792+51.1%AddedHolders
Q2 2021236,452$1.03M<0.1%−187,471−44.2%ReducedHolders
Q1 2021423,923$1.45M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.